Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-kappa B pathway

Cellular Physiology and Biochemistry

Volumn 31, Issue 2-3, 2013, Pages 230-241

  Zhang, Jing ^a   Chen, Jing ^a   Yang, Jian ^b   Xu, Chang Wu ^a   Pu, Peng ^a   Ding, Jia Wang ^b   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

Extracellular regulated protein kinase; Neointimal hyperplasia; Nuclear factor kappa B; Oxidative stress; Resveratrol; Vascular smooth muscle cells

Indexed keywords

HISTONE H3; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON CATHETER; CAROTID ARTERY; CAROTID ARTERY INJURY; CELL CULTURE; COMMON CAROTID ARTERY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; MIGRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ANIMALIA; RATTUS;

EID: 84874008167     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343364     Document Type: Article

References (47)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J: Executive summary: heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation 2010;121:948-954.
2. Clark MA, Bakhai A, Lacey MJ, Pelletier EM, Cohen DJ: Clinical and economic outcomes of percutaneous coronary interventions in the elderly: an analysis of medicare claims data. Circulation 2004;110:259-264.
3. Sousa JE, Serruys PW, Costa MA: New frontiers in cardiology: drug-eluting stents: part i. Circulation 2003;107:2274-2279.
4. Garg S, Serruys PW: Coronary stents: current status. J Am Coll Cardiol 2010;56:S1-S42.
5. Farooq V, Gogas BD, Serruys PW: Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv 2011;4:195-205.
6. Levonen AL, Vahakangas E, Koponen JK, Yla-Herttuala S: Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation 2008;117:2142-2150.
7. Griendling KK, FitzGerald GA: Oxidative stress and cardiovascular injury: part ii: animal and human studies. Circulation 2003;108:2034-2040.
8. Souza HP, Souza LC, Anastacio VM, Pereira AC, Junqueira ML, Krieger JE, Da LP, Augusto O, Laurindo FR: Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radic Biol Med 2000;28:1232-1242.
9. Janiszewski M, Pasqualucci CA, Souza LC, Pileggi F, Da LP, Laurindo FR: Oxidized thiols markedly amplify the vascular response to balloon injury in rabbits through a redox active metal-dependent pathway. Cardiovasc Res 1998;39:327-338.
10. Nunes GL, Robinson K, Kalynych A, King SR, Sgoutas DS, Berk BC: Vitamins C and E inhibit O2- production in the pig coronary artery. Circulation 1997;96:3593-3601.
11. Freyschuss A, Stiko-Rahm A, Swedenborg J, Henriksson P, Bjorkhem I, Berglund L, Nilsson J: Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest 1993;91:1282-1288.
12. Fraczek M, Szumilo J, Podlodowska J, Burdan F: [resveratrol-phytophenol with wide activity]. Pol Merkur Lekarski 2012;32:143-146.
13. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R: Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008;8:157-168.
14. Cernadas MR, Sanchez DML, Garcia-Duran M, Gonzalez-Fernandez F, Millas I, Monton M, Rodrigo J, Rico L, Fernandez P, de Frutos T, Rodriguez-Feo JA, Guerra J, Caramelo C, Casado S, Lopez-Farre: Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 1998;83:279-286.
15. Wolf G, Wenzel UO: Angiotensin ii and cell cycle regulation. Hypertension 2004;43:693-698.
16. Touyz RM, Schiffrin EL: Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin ii in vascular smooth muscle cells. Pharmacol Rev 2000;52:639-672.
17. Touyz RM: Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2000;2:98-105.
18. Griendling KK, Sorescu D, Ushio-Fukai M: Nad(p)h oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
19. Tokunou T, Shibata R, Kai H, Ichiki T, Morisaki T, Fukuyama K, Ono H, Iino N, Masuda S, Shimokawa H, Egashira K, Imaizumi T, Takeshita A: Apoptosis induced by inhibition of cyclic amp response elementbinding protein in vascular smooth muscle cells. Circulation 2003;108:1246-1252.
20. Sorescu D, Somers MJ, Lassegue B, Grant S, Harrison DG, Griendling KK: Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. Free Radic Biol Med 2001;30:603-612.
21. Yang CS, Lee HM, Lee JY, Kim JA, Lee SJ, Shin DM, Lee YH, Lee DS, El-Benna J, Jo EK: Reactive oxygen species and p47phox activation are essential for the mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia. J Neuroinflammation 2007;4:27.
22. Chen J, Jiang H, Xu L, Zhu LH, Wang L, Wen HZ, Hu XR: Dysregulation of creb binding protein triggers thrombin-induced proliferation of vascular smooth muscle cells. Mol Cell Biochem 2008;315:123-130.
23. Chen J, Jiang H, Yang J, Chen SS, Xu L: Down-regulation of creb-binding protein expression blocks thrombinmediated endothelial activation by inhibiting acetylation of NF-kappaB. Int J Cardiol 2012;154:147-152.
24. Taniyama Y, Griendling KK: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003;42:1075-1081.
25. Rao GN, Berk BC: Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992;70:593-599.
26. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T: Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995;270:296-299.
27. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996;98:2572-2579.
28. Basu S: Bioactive eicosanoids: role of prostaglandin f (2alpha) and f(2)-isoprostanes in inflammation and oxidative stress related pathology. Mol Cells 2010;30:383-391.
29. Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, Hu F, Ballabh P, Podlutsky A, Losonczy G, de Cabo R, Mathew R, Wolin MS, Ungvari Z: Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 2009;54:668-675.
30. Zhang H, Morgan B, Potter BJ, Ma L, Dellsperger KC, Ungvari Z, Zhang C: Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. Am J Physiol Heart Circ Physiol 2010;299:H985-H994.
31. Csiszar A: Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease. Ann N Y Acad Sci 2011;1215:117-122.
32. Schomer B, Epel D: Redox changes during fertilization and maturation of marine invertebrate eggs. Dev Biol 1998;203:1-11.
33. Liu DH, Chen YM, Liu Y, Hao BS, Zhou B, Wu L, Wang M, Chen L, Wu WK, Qian XX: Rb1 protects endothelial cells from hydrogen peroxide-induced cell senescence by modulating redox status. Biol Pharm Bull 2011;34:1072-1077.
34. Forman HJ, Torres M, Fukuto J: Redox signaling. Mol Cell Biochem 2002;234-235:49-62.
35. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
36. Touyz RM: Reactive oxygen species and angiotensin ii signaling in vascular cells - implications in cardiovascular disease. Braz J Med Biol Res 2004;37:1263-1273.
37. Haider UG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM: Resveratrol suppresses angiotensin iiinduced akt/protein kinase b and p70 s6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol 2002;62:772-777.
38. Kim SW, Kim CE, Kim MH: Flavonoids inhibit high glucose-induced up-regulation of icam-1 via the p38 mapk pathway in human vein endothelial cells. Biochem Biophys Res Commun 2011;415:602-607.
39. Anrather J, Racchumi G, Iadecola C: Nf-kappab regulates phagocytic nadph oxidase by inducing the expression of gp91phox. J Biol Chem 2006;281:5657-5667.
40. Li Q, Verma IM: Nf-kappab regulation in the immune system. Nat Rev Immunol 2002;2:725-734.
41. Baldwin AJ: The nf-kappa b and i kappa b proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-683.
42. Naumann M, Scheidereit C: Activation of nf-kappa b in vivo is regulated by multiple phosphorylations. Embo J 1994;13:4597-4607.
43. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S: The transcriptional activity of nf-kappab is regulated by the ikappab-associated pkac subunit through a cyclic amp-independent mechanism. Cell 1997;89:413-424.
44. Anrather J, Csizmadia V, Soares MP, Winkler H: Regulation of nf-kappab rela phosphorylation and transcriptional activity by p21 (ras) and protein kinase czeta in primary endothelial cells. J Biol Chem 1999;274:13594-13603.
45. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T: Creb-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A 1997;94:2927-2932.
46. Kannabiran C, Zeng X, Vales LD: The mammalian transcriptional repressor rbp (cbf1) regulates interleukin-6 gene expression. Mol Cell Biol 1997;17:1-9.
47. Schmitz ML, Mattioli I, Buss H, Kracht M: Nf-kappab: a multifaceted transcription factor regulated at several levels. Chembiochem 2004;5:1348-1358.